Zinc-finger proteins in health and disease.

Matteo Cassandri, Artem Smirnov, Flavia Novelli, Consuelo Pitolli, Massimiliano Agostini, Michal Malewicz, Gerry Melino, Giuseppe Raschellà
Author Information
  1. Matteo Cassandri: Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata', Rome 00133, Italy.
  2. Artem Smirnov: Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata', Rome 00133, Italy.
  3. Flavia Novelli: Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata', Rome 00133, Italy.
  4. Consuelo Pitolli: Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata', Rome 00133, Italy.
  5. Massimiliano Agostini: Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata', Rome 00133, Italy.
  6. Michal Malewicz: Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, UK.
  7. Gerry Melino: Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata', Rome 00133, Italy.
  8. Giuseppe Raschellà: ENEA Research Center Casaccia, Laboratory of Biosafety and Risk Assessment, Via Anguillarese, Rome, Italy.

Abstract

Zinc-finger proteins (ZNFs) are one of the most abundant groups of proteins and have a wide range of molecular functions. Given the wide variety of zinc-finger domains, ZNFs are able to interact with DNA, RNA, PAR (poly-ADP-ribose) and other proteins. Thus, ZNFs are involved in the regulation of several cellular processes. In fact, ZNFs are implicated in transcriptional regulation, ubiquitin-mediated protein degradation, signal transduction, actin targeting, DNA repair, cell migration, and numerous other processes. The aim of this review is to provide a comprehensive summary of the current state of knowledge of this class of proteins. Firstly, we describe the actual classification of ZNFs, their structure and functions. Secondly, we focus on the biological role of ZNFs in the development of organisms under normal physiological and pathological conditions.

References

  1. J Clin Invest. 2006 Apr;116(4):929-39 [PMID: 16557299]
  2. Nat Genet. 2006 Jun;38(6):682-7 [PMID: 16715098]
  3. Cell Death Dis. 2016 Oct 20;7(10 ):e2428 [PMID: 27763636]
  4. Eur J Cell Biol. 2016 Aug;95(8):277-84 [PMID: 27182009]
  5. Cell Death Differ. 2016 Jan;23 (1):158-68 [PMID: 26113042]
  6. Aging (Albany NY). 2015 Dec;7(12 ):1050-65 [PMID: 26668111]
  7. J Biol Chem. 1996 Aug 16;271(33):20009-17 [PMID: 8702718]
  8. Nat Rev Cancer. 2007 May;7(5):370-80 [PMID: 17457303]
  9. Mol Carcinog. 2009 Jul;48(7):618-25 [PMID: 19058297]
  10. Cell Mol Life Sci. 1999 Jan;55(1):96-107 [PMID: 10065155]
  11. Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3077-80 [PMID: 10077639]
  12. Oncology. 2017;93(3):197-203 [PMID: 28558382]
  13. Cancer Res. 2005 May 1;65(9):3811-4 [PMID: 15867378]
  14. Nature. 2005 Jun 2;435(7042):646-51 [PMID: 15806097]
  15. J Biomed Sci. 2016 Jul 13;23 (1):53 [PMID: 27411336]
  16. Nature. 2003 Apr 17;422(6933):735-8 [PMID: 12700765]
  17. Proc Natl Acad Sci U S A. 2012 Oct 2;109 (40):16202-7 [PMID: 22988117]
  18. Oncotarget. 2014 Feb 28;5(4):872-81 [PMID: 24657911]
  19. Biochem Biophys Res Commun. 2011 Sep 16;413(1):58-61 [PMID: 21888896]
  20. Stem Cells. 2011 Nov;29(11):1705-16 [PMID: 21915945]
  21. Mol Med. 1999 Feb;5(2):71-83 [PMID: 10203572]
  22. Acta Biochim Biophys Sin (Shanghai). 2008 Jul;40(7):554-64 [PMID: 18604447]
  23. Hum Genet. 2003 Dec;114(1):11-21 [PMID: 14520560]
  24. Cell. 2011 Mar 4;144(5):689-702 [PMID: 21376232]
  25. J Cell Biochem. 2015 Nov;116(11):2435-44 [PMID: 25989233]
  26. Science. 2015 Jan 23;347(6220):1260419 [PMID: 25613900]
  27. Hum Mol Genet. 2005 Apr 1;14(7):973-82 [PMID: 15731117]
  28. Dev Cell. 2012 Mar 13;22(3):669-77 [PMID: 22364861]
  29. Nucleic Acids Res. 2017 Feb 17;45(3):1114-1129 [PMID: 28180290]
  30. Mol Cell Biol. 2005 Jan;25(2):706-15 [PMID: 15632071]
  31. Elife. 2016 Oct 15;5:null [PMID: 27743478]
  32. FEBS J. 2009 Aug;276(15):4197-206 [PMID: 19583777]
  33. Cell Death Differ. 2016 Nov 1;23 (11):1886-1896 [PMID: 27612013]
  34. Cell Death Differ. 2011 Nov;18(11):1791-804 [PMID: 21566658]
  35. Genes Dev. 1997 Mar 15;11(6):714-25 [PMID: 9087426]
  36. Cell Death Differ. 2016 Aug;23 (8):1296-311 [PMID: 26990658]
  37. Mol Cell Biol. 1988 Apr;8(4):1684-96 [PMID: 2837652]
  38. Cancer Chemother Pharmacol. 2006 Apr;57(4):491-9 [PMID: 16075278]
  39. Oncotarget. 2017 Apr 24;8(31):51946-51962 [PMID: 28881702]
  40. Cell Death Dis. 2015 Oct 29;6:e1947 [PMID: 26512957]
  41. Cancer Res. 2016 Dec 1;76(23 ):6877-6887 [PMID: 27758879]
  42. Bioessays. 2007 Jun;29(6):549-57 [PMID: 17508399]
  43. Cell Death Differ. 2015 Jun;22(6):888-9 [PMID: 25941165]
  44. Nature. 2012 Nov 1;491(7422):114-8 [PMID: 23000899]
  45. Mod Pathol. 2009 Jan;22(1):66-70 [PMID: 18836421]
  46. Hum Mol Genet. 2012 Jun 15;21(12):2745-58 [PMID: 22422766]
  47. Oncogene. 2010 Jun 17;29(24):3490-500 [PMID: 20418909]
  48. Oncol Lett. 2013 Feb;5(2):564-568 [PMID: 23420790]
  49. Arch Otolaryngol Head Neck Surg. 2003 Jul;129(7):754-9 [PMID: 12874078]
  50. Trends Genet. 1994 Sep;10(9):315-20 [PMID: 7974745]
  51. Eur J Endocrinol. 2011 Mar;164(3):437-43 [PMID: 21139041]
  52. Cell Death Dis. 2016 Jun 09;7(6):e2255 [PMID: 27277677]
  53. J Pathol. 1997 May;182(1):54-61 [PMID: 9227342]
  54. Oncol Rep. 2007 May;17(5):1089-94 [PMID: 17390049]
  55. FEBS Lett. 2009 Jun 18;583(12):2108-13 [PMID: 19481545]
  56. Cell Death Dis. 2016 Jun 16;7:e2266 [PMID: 27310874]
  57. Cell Death Differ. 2008 May;15(5):841-8 [PMID: 18219319]
  58. Cardiovasc Res. 2004 Aug 1;63(2):196-207 [PMID: 15249177]
  59. Cancer Sci. 2012 Aug;103(8):1420-8 [PMID: 22632166]
  60. Development. 2003 Jun;130(12):2767-77 [PMID: 12736219]
  61. Cell Death Differ. 2015 Aug;22(8):1341-52 [PMID: 25591736]
  62. Development. 1999 Feb;126(4):723-32 [PMID: 9895320]
  63. Cell Death Differ. 2016 Dec;23 (12 ):1902-1903 [PMID: 27689875]
  64. J Biol Chem. 2011 Jul 29;286(30):26516-23 [PMID: 21602272]
  65. Cold Spring Harb Perspect Med. 2017 May 1;7(5):null [PMID: 28270530]
  66. Cell Death Dis. 2015 Dec 31;6:e2035 [PMID: 26720344]
  67. Protein Eng. 1988 Sep;2(3):209-18 [PMID: 3148934]
  68. Nat Genet. 2006 Jul;38(7):749-51 [PMID: 16751772]
  69. Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96 [PMID: 24556840]
  70. J Biol Chem. 2001 Jan 12;276(2):1026-33 [PMID: 11038368]
  71. J Biol Chem. 2009 Oct 23;284(43):29571-81 [PMID: 19654331]
  72. J Cell Sci. 1994 Jun;107 ( Pt 6):1583-91 [PMID: 7525621]
  73. Genes Dev. 1993 Jul;7(7A):1126-32 [PMID: 8319905]
  74. Cancer Res. 2008 Jan 15;68(2):537-44 [PMID: 18199550]
  75. Int J Cancer. 2001 Jan 1;91(1):8-21 [PMID: 11149424]
  76. Cell Cycle. 2015 ;14 (4):481-7 [PMID: 25607528]
  77. J Surg Oncol. 2012 Jun 15;105(8):830-4 [PMID: 22213004]
  78. Hum Mol Genet. 2007 Dec 1;16(23 ):2972-86 [PMID: 17905753]
  79. Biochim Biophys Acta. 2004 Nov 29;1695(1-3):235-47 [PMID: 15571819]
  80. J Biol Chem. 2000 Apr 28;275(17):12879-88 [PMID: 10777586]
  81. Science. 2003 May 2;300(5620):764 [PMID: 12730594]
  82. Cell Death Differ. 2010 Feb;17(2):193-9 [PMID: 19461653]
  83. Genomics. 1997 Aug 1;43(3):329-38 [PMID: 9268636]
  84. Nucleic Acids Res. 2003 Jun 1;31(11):2900-14 [PMID: 12771217]
  85. Development. 2002 Jun;129(11):2619-28 [PMID: 12015290]
  86. FEBS J. 2015 Dec;282(23):4480-96 [PMID: 26365095]
  87. Nat Genet. 2014 May;46(5):467-73 [PMID: 24686850]
  88. Nat Rev Immunol. 2017 Feb;17 (2):130-143 [PMID: 27990022]
  89. Biochem Biophys Res Commun. 1999 Aug 19;262(1):113-20 [PMID: 10448078]
  90. Cancer Res. 2003 Jul 15;63(14 ):3877-82 [PMID: 12873976]
  91. Q Rev Biophys. 2010 Feb;43(1):1-21 [PMID: 20478078]
  92. PLoS One. 2013 Aug 21;8(8):e69378 [PMID: 23990882]
  93. Curr Pharm Des. 2009;15(31):3681-96 [PMID: 19925420]
  94. Genes Dev. 2014 Sep 15;28(18):2013-26 [PMID: 25228645]
  95. Cell Death Dis. 2015 Apr 02;6:e1708 [PMID: 25837484]
  96. BMC Med Genet. 2011 Dec 20;12:167 [PMID: 22185198]
  97. EMBO J. 1997 Sep 15;16(18):5687-96 [PMID: 9312027]
  98. Cell Death Differ. 2016 Aug;23 (8):1358-70 [PMID: 26943320]
  99. Neurobiol Aging. 2004 Sep;25(8):991-9 [PMID: 15212823]
  100. FEBS Lett. 2012 Jul 30;586(16):2294-9 [PMID: 22728435]
  101. J Microbiol Biotechnol. 2016 Dec 28;26(12 ):2019-2029 [PMID: 27713215]
  102. Oncogene. 2016 Jan 21;35(3):301-13 [PMID: 25823024]
  103. J Cell Biochem. 2010 May 15;110(2):352-62 [PMID: 20235149]
  104. Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15608-12 [PMID: 9861017]
  105. Dev Biol. 2016 Feb 1;410(1):86-97 [PMID: 26688546]
  106. FEBS Lett. 2012 Jul 4;586(14):1959-70 [PMID: 22710176]
  107. J Biol Chem. 2011 Nov 4;286(44):38190-201 [PMID: 21908891]
  108. Development. 2014 Nov;141(21):4042-54 [PMID: 25336735]
  109. Cell Death Dis. 2015 Oct 22;6:e1936 [PMID: 26492369]
  110. Mol Cell Biol. 2007 Feb;27(3):1056-68 [PMID: 17116689]
  111. Genes Dev. 1997 Apr 15;11(8):1061-72 [PMID: 9136933]
  112. Gut. 2000 Apr;46(4):507-14 [PMID: 10716680]
  113. Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18668-73 [PMID: 17130451]
  114. Nat Genet. 1997 Jan;15(1):30-5 [PMID: 8988165]
  115. Oncogene. 2007 Jan 4;26(1):111-22 [PMID: 16799630]
  116. Mol Cell Biol. 2006 Dec;26(23):9060-70 [PMID: 16940177]
  117. Gastroenterology. 2011 Apr;140(4):1219-1229.e1-2 [PMID: 21262227]
  118. J Muscle Res Cell Motil. 2014 Dec;35(5-6):259-65 [PMID: 25433557]
  119. Cold Spring Harb Perspect Med. 2016 Jun 01;6(6):null [PMID: 27194168]
  120. Immunol Rev. 2015 Jul;266(1):208-21 [PMID: 26085217]
  121. Science. 2013 Feb 15;339(6121):819-23 [PMID: 23287718]
  122. Cell Death Dis. 2015 Jul 16;6:e1821 [PMID: 26181202]
  123. Mol Cell Biol. 2006 Mar;26(6):2055-64 [PMID: 16507986]
  124. Cell Death Dis. 2015 Jul 02;6:e1802 [PMID: 26136075]
  125. Nucleic Acids Res. 2015 Jan;43(Database issue):D1079-85 [PMID: 25361968]
  126. J Invest Dermatol. 2006 Jan;126(1):49-60 [PMID: 16417217]
  127. J Obstet Gynecol Neonatal Nurs. 2004 Jan-Feb;33(1):12-20 [PMID: 14971549]
  128. Mol Cell Biol. 2016 Jun 29;36(14 ):1900-7 [PMID: 27185879]
  129. Neurobiol Aging. 2012 Feb;33(2):422.e11-25 [PMID: 21112127]
  130. PLoS One. 2012;7(8):e42628 [PMID: 22936986]
  131. Pediatr Res. 2010 Oct;68(4):281-5 [PMID: 20581743]
  132. Cell. 1995 Jan 13;80(1):155-65 [PMID: 7813012]
  133. Nat Genet. 1999 Aug;22(4):356-60 [PMID: 10431239]
  134. Oncogene. 2017 Jul 13;36(28):3943-3956 [PMID: 28288132]
  135. Am J Hum Genet. 2015 Apr 2;96(4):597-611 [PMID: 25839328]
  136. J Biol Chem. 2002 Aug 23;277(34):30901-13 [PMID: 12042312]
  137. Oncogene. 2017 Apr 20;36(16):2243-2254 [PMID: 27819679]
  138. Cell Death Discov. 2015;1:null [PMID: 26998348]
  139. Mod Pathol. 2008 Aug;21(8):943-9 [PMID: 18500263]
  140. Biochem Pharmacol. 2010 Jan 15;79(2):209-17 [PMID: 19682436]
  141. EMBO J. 1998 Jan 15;17 (2):554-64 [PMID: 9430646]
  142. Biochem Biophys Res Commun. 1997 Apr 7;233(1):154-60 [PMID: 9144414]
  143. J Cell Physiol. 2017 May;232(5):1114-1122 [PMID: 27576048]
  144. Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13933-8 [PMID: 19666519]
  145. Clin Cancer Res. 2001 May;7(5):1446-51 [PMID: 11350916]
  146. Cell Death Differ. 2015 Sep;22(9):1517-25 [PMID: 25721045]
  147. Oncogene. 2016 May 19;35(20):2592-601 [PMID: 26300006]
  148. Mol Clin Oncol. 2014 Sep;2(5):709-713 [PMID: 25054034]
  149. Nat Genet. 1997 Jan;15(1):21-9 [PMID: 8988164]

Grants

  1. MC_UP_A600_1109/Medical Research Council

Word Cloud

Created with Highcharts 10.0.0ZNFsproteinsZinc-fingerwidefunctionsDNAregulationprocessesoneabundantgroupsrangemolecularGivenvarietyzinc-fingerdomainsableinteractRNAPARpoly-ADP-riboseThusinvolvedseveralcellularfactimplicatedtranscriptionalubiquitin-mediatedproteindegradationsignaltransductionactintargetingrepaircellmigrationnumerousaimreviewprovidecomprehensivesummarycurrentstateknowledgeclassFirstlydescribeactualclassificationstructureSecondlyfocusbiologicalroledevelopmentorganismsnormalphysiologicalpathologicalconditionshealthdisease

Similar Articles

Cited By